{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:44:46Z","timestamp":1791521086862,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Fund set up by Yunnan University of Chinese Medicine and its First Affiliated Hospital","award":["XYLH202339"],"award-info":[{"award-number":["XYLH202339"]}]},{"name":"Yunnan Provincial Science and Technology Department Science and Technology Programme Projects","award":["202101AZ070001-168"],"award-info":[{"award-number":["202101AZ070001-168"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20762-8","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:33:14Z","timestamp":1761039194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bioinformatics analyses of comorbid mechanisms between psoriasis and type 2 diabetes mellitus"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhimin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhou","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"20762_CR1","doi-asserted-by":"crossref","unstructured":"C. American Diabetes Association Professional Practice, 2. Diagnosis and classification of diabetes: Standards of care in diabetes-2024. Diabetes Care 47, S20\u2013S42 (2024).","DOI":"10.2337\/dc24-S002"},{"key":"20762_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/cph4.70003","volume":"15","author":"A Singh","year":"2025","unstructured":"Singh, A., Shadangi, S., Gupta, P. K. & Rana, S. Type 2 diabetes mellitus: A comprehensive review of pathophysiology, comorbidities, and emerging therapies. Compr. Physiol. 15, e70003 (2025).","journal-title":"Compr. Physiol."},{"key":"20762_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi, R. et al. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ 369, m1590 (2020).","journal-title":"BMJ"},{"key":"20762_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska, I., Pieniawska, M. & Grzywa, T. M. The immunology of psoriasis-current concepts in pathogenesis. Clin. Rev. Allergy Immunol. 66, 164\u2013191 (2024).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"20762_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jaad.2006.09.017","volume":"56","author":"J Shapiro","year":"2007","unstructured":"Shapiro, J. et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study. J. Am. Acad. Dermatol. 56, 629\u2013634 (2007).","journal-title":"J. Am. Acad. Dermatol."},{"key":"20762_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2133.2008.08814.x","volume":"159","author":"YB Brauchli","year":"2008","unstructured":"Brauchli, Y. B., Jick, S. S. & Meier, C. R. Psoriasis and the risk of incident diabetes mellitus: A population-based study. Br. J. Dermatol. 159, 1331\u20131337 (2008).","journal-title":"Br. J. Dermatol."},{"key":"20762_CR7","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1136\/ard.2009.125476","volume":"69","author":"DH Solomon","year":"2010","unstructured":"Solomon, D. H., Love, T. J., Canning, C. & Schneeweiss, S. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann. Rheum. Dis. 69, 2114\u20132117 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"20762_CR8","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","volume":"20","author":"K Kamiya","year":"2019","unstructured":"Kamiya, K., Kishimoto, M., Sugai, J., Komine, M. & Ohtsuki, M. Risk factors for the development of psoriasis. Int. J. Mol. Sci. 20, 4347 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"20762_CR9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.dsx.2019.01.009","volume":"13","author":"M Mamizadeh","year":"2019","unstructured":"Mamizadeh, M., Tardeh, Z. & Azami, M. The association between psoriasis and diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab. Syndr. 13, 1405\u20131412 (2019).","journal-title":"Diabetes Metab. Syndr."},{"key":"20762_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","volume":"149","author":"AW Armstrong","year":"2013","unstructured":"Armstrong, A. W., Harskamp, C. T. & Armstrong, E. J. Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis. JAMA Dermatol. 149, 84\u201391 (2013).","journal-title":"JAMA Dermatol."},{"key":"20762_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/bjd.12473","volume":"169","author":"P Coto-Segura","year":"2013","unstructured":"Coto-Segura, P. et al. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis. Br. J. Dermatol. 169, 783\u2013793 (2013).","journal-title":"Br. J. Dermatol."},{"key":"20762_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaad.2017.10.050","volume":"78","author":"MT Wan","year":"2018","unstructured":"Wan, M. T. et al. Psoriasis and the risk of diabetes: A prospective population-based cohort study. J. Am. Acad. Dermatol. 78, 315-322 e311 (2018).","journal-title":"J. Am. Acad. Dermatol."},{"key":"20762_CR13","doi-asserted-by":"publisher","first-page":"724278","DOI":"10.3389\/fendo.2021.724278","volume":"12","author":"J Kang","year":"2021","unstructured":"Kang, J. et al. Identification of shared genes and pathways in periodontitis and type 2 diabetes by bioinformatics analysis. Front. Endocrinol. (Lausanne) 12, 724278 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"20762_CR14","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D. et al. STRING v10: Protein\u2013protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447-452 (2015).","journal-title":"Nucleic Acids Res."},{"key":"20762_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."},{"key":"20762_CR16","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10753-023-01815-4","volume":"46","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Bioinformatic analysis of the potential common pathogenic mechanisms for psoriasis and metabolic syndrome. Inflammation 46, 1381\u20131395 (2023).","journal-title":"Inflammation"},{"key":"20762_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010247","volume":"5","author":"M Suarez-Farinas","year":"2010","unstructured":"Suarez-Farinas, M., Lowes, M. A., Zaba, L. C. & Krueger, J. G. Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS ONE 5, e10247 (2010).","journal-title":"PLoS ONE"},{"key":"20762_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 18, 248\u2013262 (2017).","journal-title":"Cell Rep."},{"key":"20762_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12920-022-01300-1","volume":"15","author":"Y Chu","year":"2022","unstructured":"Chu, Y. et al. Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation. BMC Med. Genomics 15, 150 (2022).","journal-title":"BMC Med. Genomics"},{"key":"20762_CR20","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"20762_CR21","doi-asserted-by":"publisher","first-page":"bav095","DOI":"10.1093\/database\/bav095","volume":"2015","author":"ZP Liu","year":"2015","unstructured":"Liu, Z. P., Wu, C., Miao, H. & Wu, H. RegNetwork: An integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database (Oxford) 2015, bav095 (2015).","journal-title":"Database (Oxford)"},{"key":"20762_CR22","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.1038\/s41598-023-34021-1","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. & Kiryu, H. Identification of oxidative stress-related genes differentially expressed in Alzheimer\u2019s disease and construction of a hub gene-based diagnostic model. Sci. Rep. 13, 6817 (2023).","journal-title":"Sci. Rep."},{"key":"20762_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1365-4632.2009.04358.x","volume":"49","author":"AS Karadag","year":"2010","unstructured":"Karadag, A. S. et al. Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis. Int. J. Dermatol. 49, 642\u2013646 (2010).","journal-title":"Int. J. Dermatol."},{"key":"20762_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jcla.21850","volume":"30","author":"G Okan","year":"2016","unstructured":"Okan, G., Baki, A. M., Yorulmaz, E., Dogru-Abbasoglu, S. & Vural, P. Serum visfatin, fetuin-A, and pentraxin 3 levels in patients with psoriasis and their relation to disease severity. J. Clin. Lab. Anal. 30, 284\u2013289 (2016).","journal-title":"J. Clin. Lab. Anal."},{"key":"20762_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/2193-1801-3-612","volume":"3","author":"M Albareda","year":"2014","unstructured":"Albareda, M. et al. Metabolic syndrome and its components in patients with psoriasis. Springerplus 3, 612 (2014).","journal-title":"Springerplus"},{"key":"20762_CR26","doi-asserted-by":"publisher","first-page":"13167","DOI":"10.3390\/ijerph182413167","volume":"18","author":"A Karpinska-Mirecka","year":"2021","unstructured":"Karpinska-Mirecka, A., Bartosinska, J. & Krasowska, D. The impact of hypertension, diabetes, lipid disorders, overweight\/obesity and nicotine dependence on health-related quality of life and psoriasis severity in psoriatic patients receiving systemic conventional and biological treatment. Int. J. Environ. Res. Public Health 18, 13167 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"20762_CR27","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jid.2020.11.025","volume":"141","author":"MT Patrick","year":"2021","unstructured":"Patrick, M. T. et al. Causal relationship and shared genetic loci between psoriasis and type 2 diabetes through trans-disease meta-analysis. J. Investig. Dermatol. 141, 1493\u20131502 (2021).","journal-title":"J. Investig. Dermatol."},{"key":"20762_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.2147\/DMSO.S312420","volume":"14","author":"S Wen","year":"2021","unstructured":"Wen, S. et al. Psoriasis exacerbates the state of insulin resistance in patients with Type 2 diabetes. Diabetes .Metab Syndr. Obes. 14, 2389\u20132397 (2021).","journal-title":"Diabetes .Metab Syndr. Obes."},{"key":"20762_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/ITT.S499605","volume":"14","author":"A Berbudi","year":"2025","unstructured":"Berbudi, A., Khairani, S. & Tjahjadi, A. I. Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: Implications for therapeutic interventions. Immunotargets Ther. 14, 359\u2013382 (2025).","journal-title":"Immunotargets Ther."},{"key":"20762_CR30","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/1744666X.2016.1204232","volume":"12","author":"F Rahmani","year":"2016","unstructured":"Rahmani, F. & Rezaei, N. Therapeutic targeting of toll-like receptors: A review of toll-like receptors and their signaling pathways in psoriasis. Expert Rev. Clin. Immunol. 12, 1289\u20131298 (2016).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"20762_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","volume":"50","author":"JQ Chen","year":"2016","unstructured":"Chen, J. Q., Szodoray, P. & Zeher, M. Toll-like receptor pathways in autoimmune diseases. Clin. Rev. Allergy Immunol. 50, 1\u201317 (2016).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"20762_CR32","doi-asserted-by":"publisher","first-page":"1824624","DOI":"10.1155\/2019\/1824624","volume":"2019","author":"L Sun","year":"2019","unstructured":"Sun, L., Liu, W. & Zhang, L. J. The role of toll-like receptors in skin host defense, psoriasis, and atopic dermatitis. J. Immunol. Res. 2019, 1824624 (2019).","journal-title":"J. Immunol. Res."},{"key":"20762_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.834485","volume":"12","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z., Sun, B., Yu, D. & Zhu, C. Gut microbiota: An important player in type 2 diabetes mellitus. Front. Cell. Infect. Microbiol. 12, 834485 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"20762_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","volume":"11","author":"TPM Scheithauer","year":"2020","unstructured":"Scheithauer, T. P. M. et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front. Immunol. 11, 571731 (2020).","journal-title":"Front. Immunol."},{"key":"20762_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.833544","volume":"12","author":"S Riedel","year":"2021","unstructured":"Riedel, S., Pheiffer, C., Johnson, R., Louw, J. & Muller, C. J. F. Intestinal barrier function and immune homeostasis are missing links in obesity and type 2 diabetes development. Front. Endocrinol. (Lausanne) 12, 833544 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"20762_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc09-1799","volume":"33","author":"MR Dasu","year":"2010","unstructured":"Dasu, M. R., Devaraj, S., Park, S. & Jialal, I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33, 861\u2013868 (2010).","journal-title":"Diabetes Care"},{"key":"20762_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/mi.2017.114","volume":"11","author":"P Lu","year":"2018","unstructured":"Lu, P. et al. Intestinal epithelial Toll-like receptor 4 prevents metabolic syndrome by regulating interactions between microbes and intestinal epithelial cells in mice. Mucosal Immunol. 11, 727\u2013740 (2018).","journal-title":"Mucosal Immunol."},{"key":"20762_CR38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1093\/abbs\/gmt092","volume":"45","author":"J Li","year":"2013","unstructured":"Li, J. et al. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction. Acta Biochim. Biophys. Sin. (Shanghai) 45, 1030\u20131038 (2013).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"20762_CR39","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Investig. 116, 3015\u20133025 (2006).","journal-title":"J. Clin. Investig."},{"key":"20762_CR40","doi-asserted-by":"publisher","first-page":"22745","DOI":"10.1038\/srep22745","volume":"6","author":"MH Tervaniemi","year":"2016","unstructured":"Tervaniemi, M. H. et al. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis. Sci. Rep. 6, 22745 (2016).","journal-title":"Sci. Rep."},{"key":"20762_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114036","volume":"147","author":"S Lai","year":"2025","unstructured":"Lai, S. et al. Knockdown of GSDMD inhibits pyroptosis in psoriasis by blocking the NOD-like receptor signaling pathway. Int. Immunopharmacol. 147, 114036 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"20762_CR42","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cyto.2013.08.003","volume":"64","author":"A Shiny","year":"2013","unstructured":"Shiny, A. et al. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes. Cytokine 64, 564\u2013570 (2013).","journal-title":"Cytokine"},{"key":"20762_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100610","volume":"46","author":"ELR Rodrigues","year":"2023","unstructured":"Rodrigues, E. L. R. et al. Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes. Biomed. J. 46, 100610 (2023).","journal-title":"Biomed. J."},{"key":"20762_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-021-00554-y","volume":"6","author":"L Yu","year":"2021","unstructured":"Yu, L. & Liu, P. Cytosolic DNA sensing by cGAS: Regulation, function, and human diseases. Signal Transduct. Target. Ther. 6, 170 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"20762_CR45","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jid.2021.08.430","volume":"142","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. Cytosolic DNA-mediated STING-dependent inflammation contributes to the progression of psoriasis. J. Investig Dermatol. 142, 898\u2013906 (2022).","journal-title":"J. Investig Dermatol."},{"key":"20762_CR46","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41423-024-01160-y","volume":"21","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production. Cell. Mol. Immunol. 21, 738\u2013751 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"20762_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134210","volume":"278","author":"S Mohammadi","year":"2024","unstructured":"Mohammadi, S. & Khorasani, M. Implications of the cGAS-STING pathway in diabetes: Risk factors and therapeutic strategies. Int. J. Biol. Macromol. 278, 134210 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"20762_CR48","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101988R","volume":"36","author":"H Hu","year":"2022","unstructured":"Hu, H. et al. cGAS-STING mediates cytoplasmic mitochondrial-DNA-induced inflammatory signal transduction during accelerated senescence of pancreatic beta-cells induced by metabolic stress. FASEB J. 36, e22266 (2022).","journal-title":"FASEB J."},{"key":"20762_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gene.2005.05.012","volume":"357","author":"E Alvarez","year":"2005","unstructured":"Alvarez, E., Zhou, W., Witta, S. E. & Freed, C. R. Characterization of the Bex gene family in humans, mice, and rats. Gene 357, 18\u201328 (2005).","journal-title":"Gene"},{"key":"20762_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1369\/jhc.5A6808.2005","volume":"54","author":"AE Enayetallah","year":"2006","unstructured":"Enayetallah, A. E., French, R. A., Barber, M. & Grant, D. F. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues. J. Histochem. Cytochem. 54, 329\u2013335 (2006).","journal-title":"J. Histochem. Cytochem."},{"key":"20762_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0006-2952(80)90518-3","volume":"29","author":"SS Gill","year":"1980","unstructured":"Gill, S. S. & Hammock, B. D. Distribution and properties of a mammalian soluble epoxide hydrase. Biochem. Pharmacol. 29, 389\u2013395 (1980).","journal-title":"Biochem. Pharmacol."},{"key":"20762_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.00021.2011","volume":"92","author":"JD Imig","year":"2012","unstructured":"Imig, J. D. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol. Rev. 92, 101\u2013130 (2012).","journal-title":"Physiol. Rev."},{"key":"20762_CR53","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","volume":"8","author":"JD Imig","year":"2009","unstructured":"Imig, J. D. & Hammock, B. D. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat. Rev. Drug Discov. 8, 794\u2013805 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"20762_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108484","volume":"86","author":"K Hildreth","year":"2020","unstructured":"Hildreth, K., Kodani, S. D., Hammock, B. D. & Zhao, L. Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: A review of recent studies. J. Nutr. Biochem. 86, 108484 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"20762_CR55","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm0597-562","volume":"3","author":"MF Moghaddam","year":"1997","unstructured":"Moghaddam, M. F. et al. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat. Med. 3, 562\u2013566 (1997).","journal-title":"Nat. Med."},{"key":"20762_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau, C. & Hammock, B. D. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu. Rev. Pharmacol. Toxicol. 53, 37\u201358 (2013).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"20762_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/db21-0298","volume":"71","author":"K Ghoshal","year":"2021","unstructured":"Ghoshal, K. et al. EET analog treatment improves insulin signaling in a genetic mouse model of insulin resistance. Diabetes 71, 83\u201392 (2021).","journal-title":"Diabetes"},{"key":"20762_CR58","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/HYPERTENSIONAHA.121.17659","volume":"78","author":"JM Luther","year":"2021","unstructured":"Luther, J. M. et al. GSK2256294 decreases sEH (soluble epoxide hydrolase) activity in plasma, muscle, and adipose and reduces F2-isoprostanes but does not alter insulin sensitivity in humans. Hypertension 78, 1092\u20131102 (2021).","journal-title":"Hypertension"},{"key":"20762_CR59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1124\/mol.64.2.482","volume":"64","author":"BD Przybyla-Zawislak","year":"2003","unstructured":"Przybyla-Zawislak, B. D. et al. Polymorphisms in human soluble epoxide hydrolase. Mol. Pharmacol. 64, 482\u2013490 (2003).","journal-title":"Mol. Pharmacol."},{"key":"20762_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.prostaglandins.2014.08.001","volume":"113\u2013115","author":"CE Ramirez","year":"2014","unstructured":"Ramirez, C. E. et al. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans. Prostaglandins Other Lipid Mediat. 113\u2013115, 38\u201344 (2014).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"20762_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbrc.2005.03.171","volume":"331","author":"K Ohtoshi","year":"2005","unstructured":"Ohtoshi, K. et al. Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients. Biochem. Biophys. Res. Commun. 331, 347\u2013350 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20762_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12937-023-00862-9","volume":"22","author":"S Lai","year":"2023","unstructured":"Lai, S. et al. Genetic variants in epoxyeicosatrienoic acid processing and degradation pathways are associated with gestational diabetes mellitus. Nutr. J. 22, 31 (2023).","journal-title":"Nutr. J."},{"key":"20762_CR63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2133\/dmpk.24.438","volume":"24","author":"A Oguro","year":"2009","unstructured":"Oguro, A., Fujita, N. & Imaoka, S. Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: High glucose suppresses sEH expression. Drug Metab. Pharmacokinet. 24, 438\u2013445 (2009).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"20762_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/BJ20150397","volume":"470","author":"A Oguro","year":"2015","unstructured":"Oguro, A., Oida, S. & Imaoka, S. Down-regulation of EPHX2 gene transcription by Sp1 under high-glucose conditions. Biochem. J. 470, 281\u2013291 (2015).","journal-title":"Biochem. J."},{"key":"20762_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116127","volume":"171","author":"Z Naeem","year":"2024","unstructured":"Naeem, Z. et al. Role of the soluble epoxide hydrolase in keratinocyte proliferation and sensitivity of skin to inflammatory stimuli. Biomed. Pharmacother. 171, 116127 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"20762_CR66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/1568026620666201202102448","volume":"21","author":"J Kaeffer","year":"2021","unstructured":"Kaeffer, J., Zeder-Lutz, G., Simonin, F. & Lecat, S. GPRASP\/ARMCX protein family: Potential involvement in health and diseases revealed by their novel interacting partners. Curr. Top. Med. Chem. 21, 227\u2013254 (2021).","journal-title":"Curr. Top. Med. Chem."},{"key":"20762_CR67","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2010.03.004","volume":"126","author":"A Abu-Helo","year":"2010","unstructured":"Abu-Helo, A. & Simonin, F. Identification and biological significance of G protein-coupled receptor associated sorting proteins (GASPs). Pharmacol. Ther. 126, 244\u2013250 (2010).","journal-title":"Pharmacol. Ther."},{"key":"20762_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154374","volume":"243","author":"J Du","year":"2023","unstructured":"Du, J. et al. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer. Pathol. Res. Pract. 243, 154374 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"20762_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.659977","volume":"12","author":"JS Steinhoff","year":"2021","unstructured":"Steinhoff, J. S., Lass, A. & Schupp, M. Biological functions of RBP4 and its relevance for human diseases. Front. Physiol. 12, 659977 (2021).","journal-title":"Front. Physiol."},{"key":"20762_CR70","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1089\/jmf.2020.0147","volume":"24","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Wang, T., Hu, X. & Chen, G. Vitamin A and diabetes. J Med Food 24, 775\u2013785 (2021).","journal-title":"J Med Food"},{"key":"20762_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12986-019-0423-y","volume":"17","author":"HM Wang","year":"2020","unstructured":"Wang, H. M., Wu, C., Jiang, Y. Y., Wang, W. M. & Jin, H. Z. Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model. Nutr. Metab. (Lond.) 17, 5 (2020).","journal-title":"Nutr. Metab. (Lond.)"},{"key":"20762_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1464-5491.2007.02314.x","volume":"25","author":"C Hu","year":"2008","unstructured":"Hu, C. et al. Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population. Diabet. Med. 25, 11\u201318 (2008).","journal-title":"Diabet. Med."},{"key":"20762_CR73","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature03711","volume":"436","author":"Q Yang","year":"2005","unstructured":"Yang, Q. et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356\u2013362 (2005).","journal-title":"Nature"},{"key":"20762_CR74","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2014.01.018","volume":"19","author":"PM Moraes-Vieira","year":"2014","unstructured":"Moraes-Vieira, P. M. et al. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell. Metab. 19, 512\u2013526 (2014).","journal-title":"Cell. Metab."},{"key":"20762_CR75","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2337\/db15-1696","volume":"65","author":"PM Moraes-Vieira","year":"2016","unstructured":"Moraes-Vieira, P. M. et al. Antigen presentation and T-cell activation are critical for RBP4-induced insulin resistance. Diabetes 65, 1317\u20131327 (2016).","journal-title":"Diabetes"},{"key":"20762_CR76","doi-asserted-by":"publisher","first-page":"31309","DOI":"10.1073\/pnas.2013877117","volume":"117","author":"PM Moraes-Vieira","year":"2020","unstructured":"Moraes-Vieira, P. M. et al. Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4. Proc. Natl. Acad. Sci. U. S. A. 117, 31309\u201331318 (2020).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"20762_CR77","doi-asserted-by":"publisher","first-page":"1208969","DOI":"10.3389\/fmed.2023.1208969","volume":"10","author":"G Gao","year":"2023","unstructured":"Gao, G., Cui, Y. & Cheng, H. Association between retinol binding protein-4 and psoriasis vulgaris: A systematic review and meta-analysis. Front. Med. (Lausanne) 10, 1208969 (2023).","journal-title":"Front. Med. (Lausanne)"},{"key":"20762_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12865-024-00647-7","volume":"25","author":"R Niu","year":"2024","unstructured":"Niu, R. et al. Pre-treatment plasma retinol binding protein 4 level and its change after treatments predict systemic treatment response in psoriasis patients. BMC Immunol. 25, 55 (2024).","journal-title":"BMC Immunol."},{"key":"20762_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622306","volume":"12","author":"UC Kucuksezer","year":"2021","unstructured":"Kucuksezer, U. C. et al. The role of natural killer cells in autoimmune diseases. Front. Immunol. 12, 622306 (2021).","journal-title":"Front. Immunol."},{"key":"20762_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31266","volume":"239","author":"AAM Noor","year":"2024","unstructured":"Noor, A. A. M., Nor, A. & Redzwan, N. M. The immunological understanding on germinal center B cells in psoriasis. J. Cell. Physiol. 239, e31266 (2024).","journal-title":"J. Cell. Physiol."},{"key":"20762_CR81","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1038\/s41598-021-81588-8","volume":"11","author":"K Mizumaki","year":"2021","unstructured":"Mizumaki, K., Horii, M., Kano, M., Komuro, A. & Matsushita, T. Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells. Sci. Rep. 11, 2106 (2021).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20762-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20762-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20762-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:02:04Z","timestamp":1761429724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20762-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20762"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20762-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36772"}}